These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23513868)

  • 1. [New drug targets for the metabolic syndrome and obesity].
    Okada-Iwabu M; Yamauchi T; Kadowaki T
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():372-7. PubMed ID: 23513868
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
    Yamauchi T; Kadowaki T
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating adiponectin and adiponectin receptor expression in skeletal muscle: effects of exercise.
    Vu V; Riddell MC; Sweeney G
    Diabetes Metab Res Rev; 2007 Nov; 23(8):600-11. PubMed ID: 17966120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and function of adiponectin receptors in skeletal muscle.
    Lustig Y; Hemi R; Kanety H
    Vitam Horm; 2012; 90():95-123. PubMed ID: 23017713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.
    Kadowaki T; Yamauchi T; Kubota N; Hara K; Ueki K; Tobe K
    J Clin Invest; 2006 Jul; 116(7):1784-92. PubMed ID: 16823476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin--a key adipokine in the metabolic syndrome.
    Whitehead JP; Richards AA; Hickman IJ; Macdonald GA; Prins JB
    Diabetes Obes Metab; 2006 May; 8(3):264-80. PubMed ID: 16634986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adiponectin and insulin resistance].
    Kovácová Z; Stich V; Polák J
    Vnitr Lek; 2007 Nov; 53(11):1142-3. PubMed ID: 18277621
    [No Abstract]   [Full Text] [Related]  

  • 8. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice.
    Goto T; Teraminami A; Lee JY; Ohyama K; Funakoshi K; Kim YI; Hirai S; Uemura T; Yu R; Takahashi N; Kawada T
    J Nutr Biochem; 2012 Jul; 23(7):768-76. PubMed ID: 21889885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puerarin improves insulin resistance and modulates adipokine expression in rats fed a high-fat diet.
    Zhang W; Liu CQ; Wang PW; Sun SY; Su WJ; Zhang HJ; Li XJ; Yang SY
    Eur J Pharmacol; 2010 Dec; 649(1-3):398-402. PubMed ID: 20869961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults.
    O'Leary VB; Jorett AE; Marchetti CM; Gonzalez F; Phillips SA; Ciaraldi TP; Kirwan JP
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E421-7. PubMed ID: 17488807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin: a key adipocytokine in metabolic syndrome.
    Okamoto Y; Kihara S; Funahashi T; Matsuzawa Y; Libby P
    Clin Sci (Lond); 2006 Mar; 110(3):267-78. PubMed ID: 16464169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin and PPARγ: cooperative and interdependent actions of two key regulators of metabolism.
    Astapova O; Leff T
    Vitam Horm; 2012; 90():143-62. PubMed ID: 23017715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.
    Liu Y; Chewchuk S; Lavigne C; Brûlé S; Pilon G; Houde V; Xu A; Marette A; Sweeney G
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E657-64. PubMed ID: 19531641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
    Yamagishi S; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(3):609-11. PubMed ID: 16171951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone.
    Jang C; Inder WJ; Obeyesekere VR; Alford FP
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):745-50. PubMed ID: 18363889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy.
    Oike Y; Akao M; Kubota Y; Suda T
    Trends Mol Med; 2005 Oct; 11(10):473-9. PubMed ID: 16154386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS.
    Kadowaki T; Yamauchi T; Kubota N
    FEBS Lett; 2008 Jan; 582(1):74-80. PubMed ID: 18054335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
    Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.